
AI is about to change healthcare. These 39 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
To own Xometry, you generally need to believe its AI powered marketplace can grow volumes and gradually improve margins while moving closer to consistent profitability. The latest AI upgrades may support the near term catalyst of margin improvement by sharpening pricing and sourcing, but they also amplify a key risk: ongoing heavy technology spending that has not yet translated into GAAP profits and could, if results disappoint, pressure the company to raise more capital again.
Among recent developments, the US$225,000,000 follow on equity offering in June 2026 stands out in light of these AI enhancements. The raise increases financial flexibility to keep investing in technology and marketplace expansion, but it also adds to dilution concerns that sit alongside execution risk on these new AI models. How effectively Xometry converts this combination of fresh capital and upgraded AI into higher quality revenue growth will be central to the near term investment debate.
Yet even with stronger AI, investors should be aware that persistent unprofitability and potential future dilution could still...
Read the full narrative on Xometry (it's free!)
Xometry's narrative projects $1.3 billion revenue and $74.4 million earnings by 2029. This requires 20.2% yearly revenue growth and a $126.3 million earnings increase from -$51.9 million today.
Uncover how Xometry's forecasts yield a $89.25 fair value, a 9% downside to its current price.
Some of the most optimistic analysts once projected about US$1.4 billion in 2029 revenue and over US$100 million in earnings, yet this latest AI upgrade and the risk that large OEMs might increasingly bypass third party platforms show how sharply views can differ and how those forecasts could still shift.
Explore 4 other fair value estimates on Xometry - why the stock might be worth less than half the current price!
Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.
These stocks are moving-our analysis flagged them today. Act fast before the price catches up:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com